References
- SiegelRNaishadhamDJemalACancer statistics, 2013CA Cancer J Clin2013631113023335087
- KimKZangRChoiSCRyuSYKimJWCurrent status of gyneco-logical cancer in ChinaJ Gynecol Oncol2009202727619590717
- ThigpenTduBoisAMcAlpineJGynecologic Cancer InterGroupFirst-line therapy in ovarian cancer trialsInt J Gynecol Cancer201121475676221543937
- VaughanSCowardJIBastRCJrRethinking ovarian cancer: recommendations for improving outcomesNat Rev Cancer2011111071972521941283
- ZongWXThompsonCBNecrotic death as a cell fateGenes Dev200620111516391229
- VanlangenakkerNVanden BergheTVandenabeelePMany stimuli pull the necrotic trigger, an overviewCell Death Differ2012191758622075985
- TenevTBianchiKDardingMThe Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPsMol Cell201143343244821737329
- VandenabeelePGalluzziLVanden BergheTKroemerGMolecular mechanisms of necroptosis: an ordered cellular explosionNat Rev Mol Cell Biol2010111070071420823910
- SunLWangHWangZMixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinaseCell20121481–221322722265413
- ZhaoJJitkaewSCaiZMixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosisProc Natl Acad Sci U S A2012109145322532722421439
- KimYSMorganMJChoksiSLiuZGTNF-induced activation of the Nox1 NADPH oxidase and its role in the induction of necrotic cell deathMol Cell200726567568717560373
- JørgensenKDavidsonBFlørenesVAActivation of c-jun N-terminal kinase is associated with cell proliferation and shorter relapse-free period in superficial spreading malignant melanomaMod Pathol200619111446145516951673
- KuoRCLinCYKuoMYPrognostic role of c-Jun activation in patients with areca quid chewing-related oral squamous cell carcinomas in TaiwanJ Formos Med Assoc2006105322923416520839
- ColbertLEFisherSBHardyCWPronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic adenocarcinomaCancer2013119173148315523720157
- PhamDLSchebleVBareissPSOX2 expression and prognostic significance in ovarian carcinomaInt J Gynecol Pathol201332435836723722508
- QiuJJGuoJJLvTJPrognostic value of centromere protein-A expression in patients with epithelial ovarian cancerTumour Biol2013
- VakifahmetogluHOlssonMTammCHeidariNOrreniusSZhivotovskyBDNA damage induces two distinct modes of cell death in ovarian carcinomasCell Death Differ200815355556618064041
- ZhangLJHaoYZHuCSInhibition of apoptosis facilitates necrosis induced by cisplatin in gastric cancer cellsAnticancer Drugs200819215916618176112
- PalmieriCGojisORudrarajuBExpression of steroid receptor coactivator 3 in ovarian epithelial cancer is a poor prognostic factor and a marker for platinum resistanceBr J Cancer2013108102039204423652306
- CalifanoDPignataSLositoNSHigh HMGA2 expression and high body mass index negatively affect the prognosis of patients with ovarian cancerJ Cell Physiol20142291535923765903
- ZhouSTangLWangHOverexpression of c-Abl predicts unfa-vorable outcome in epithelial ovarian cancerGynecol Oncol2013